Generic Norvasc May Launch Sooner Than Expected Following Appellate Court Ruling
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer’s hypertension treatment was predicted to go generic in September.
You may also be interested in...
Norvasc Generic Substitution Rate Reaches Nearly 77 Percent
Rate has increased nearly five fold since amlodipine generics hit the market.
Norvasc Generic Substitution Rate Reaches Nearly 77 Percent
Rate has increased nearly five fold since amlodipine generics hit the market.
Mylan, Pfizer On The Same Side Over FDA Approval Of Pending Norvasc ANDAs
FDA is expected to render a decision on approving additional amlodipine ANDAs on April 11.